Evidence map›Paper›PMID 39278989›Full record

ReviewOncogene2024

Recent insights into the causes and consequences of chromosome mis-segregation.

Romain Devillers, Alexsandro Dos Santos, Quentin Destombes, Mathieu Laplante, Sabine Elowe

Abstract readReview
PubMed Publisher
In one paragraph

Review in Oncogene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Romain DevillersCentre de Recherche sur le Cancer, CHU de Québec-Université Laval, Québec City, QC, Canada.
Alexsandro Dos SantosCentre de Recherche sur le Cancer, CHU de Québec-Université Laval, Québec City, QC, Canada.
Quentin DestombesCentre de Recherche sur le Cancer, CHU de Québec-Université Laval, Québec City, QC, Canada.
Mathieu LaplanteCentre de Recherche sur le Cancer, CHU de Québec-Université Laval, Québec City, QC, Canada.ORCID 0000-0002-1752-6741
Sabine EloweCentre de Recherche sur le Cancer, CHU de Québec-Université Laval, Québec City, QC, Canada. sabine.elowe@crchudequebec.ulaval.ca.ORCID 0000-0002-1212-7039

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJT186170
6 · The paper itself

Abstract

Mitotic cells face the challenging task of ensuring accurate and equal segregation of their duplicated, condensed chromosomes between the nascent daughter cells. Errors in the process result in chromosome missegregation, a significant consequence of which is the emergence of aneuploidy-characterized by an imbalance in chromosome number-and the associated phenomenon of chromosome instability (CIN). Aneuploidy and CIN are common features of cancer, which leverages them to promote genome heterogeneity and plasticity, thereby facilitating rapid tumor evolution. Recent research has provided insights into how mitotic errors shape cancer genomes by inducing both numerical and structural chromosomal changes that drive tumor initiation and progression. In this review, we survey recent findings regarding the mitotic causes and consequences of aneuploidy. We discuss new findings into the types of chromosome segregation errors that lead to aneuploidy and novel pathways that protect genome integrity during mitosis. Finally, we describe new developments in our understanding of the immediate consequences of chromosome mis-segregation on the genome stability of daughter cells.

Indexed as

AneuploidyChromosomal InstabilityChromosome SegregationMitosisNeoplasmsAnimalsGenomic InstabilityHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.